glp for type 1 diabetes How GLP-1 medications are transforming and weight loss treatment The role of GLP-1 and

New technologies are allowing selective identification of subsets or sub-states of reactive astrocytes, and have identified a role for a potentially therapeutically targetable mechanism that limits XBP1-driven pathogenic astrocyte responses

De Vos CHR, Kraak HL, Bino RJ (1994) Ageing of tomato seeds involves glutathione oxidation

Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection

mito GCL decreases ROS in neurons and is neuroprotective Neurons are particularly vulnerable against excess ROS, hence requiring continuous supply and regeneration of GSH for survival 15

Future Developments in Weight Loss Drugs The future trajectory of weight loss drugs is not solely determined by their potency and market value estimated to be worth $90 billion